BASEJUMPER Trademark

Trademark Overview


On Wednesday, March 24, 2021, a trademark application was filed for BASEJUMPER with the United States Patent and Trademark Office. The USPTO has given the BASEJUMPER trademark a serial number of 90979307. The federal status of this trademark filing is REGISTERED as of Tuesday, April 18, 2023. This trademark is owned by BioSkryb, Inc.. The BASEJUMPER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Genomic, proteomic, transcriptomic, epigenomic, metabolomic, and microbiomic analysis and sequencing services for scientific and research purposes; providing scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and info...
basejumper

General Information


Serial Number90979307
Word MarkBASEJUMPER
Filing DateWednesday, March 24, 2021
Status700 - REGISTERED
Status DateTuesday, April 18, 2023
Registration Number7032252
Registration DateTuesday, April 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Pseudo MarkBASE JUMPER
Goods and ServicesGenomic, proteomic, transcriptomic, epigenomic, metabolomic, and microbiomic analysis and sequencing services for scientific and research purposes; providing scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; providing temporary use of non-downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; providing temporary use of non-downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; providing temporary use of non-downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing temporary use of non-downloadable computer software for use in connection with medical diagnostic testing, monitoring, and reporting; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code042
First Use Anywhere DateWednesday, November 9, 2022
First Use In Commerce DateWednesday, November 9, 2022

Trademark Owner History


Party NameBIOSKRYB GENOMICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameBIOSKRYB GENOMICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameBIOSKRYB GENOMICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameBioSkryb, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Trademark Events


Event DateEvent Description
Tuesday, April 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 18, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, March 11, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 10, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 29, 2022USE AMENDMENT FILED
Thursday, March 9, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, December 29, 2022DIVISIONAL REQUEST RECEIVED
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 29, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 29, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, November 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2022SOU EXTENSION 1 GRANTED
Monday, October 31, 2022SOU EXTENSION 1 FILED
Monday, October 31, 2022TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 17, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 17, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 2, 2021NON-FINAL ACTION E-MAILED
Monday, August 2, 2021NON-FINAL ACTION WRITTEN
Monday, July 26, 2021ASSIGNED TO EXAMINER
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 2, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, March 27, 2021NEW APPLICATION ENTERED